KO Stock Analysis: The Coca-Cola | NYSE
Beverages - Non-Alcoholic | NYSE, USA | Market Cap: 395.834m USD | 12M Return: 40.1% | US1912161007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.38B
EPS Trend: 98.2%
Qual. Beats: 5
Rev. Trend: 95.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Coca-Cola Company is a global nonalcoholic beverage manufacturer founded in 1886 and headquartered in Atlanta, Georgia. It produces and sells sparkling soft drinks, water, sports drinks, coffee, tea, juices, value-added dairy, and plant-based beverages under a broad portfolio of brands, including Coca-Cola, Diet Coke, Sprite, Fanta, Dasani, Smartwater, Powerade, Costa, and fairlife. The company also sells beverage concentrates, syrups, and fountain syrups to restaurant and convenience store retailers.
The company operates a concentrate-based business model, generating revenue primarily by selling syrups and concentrates to a global network of independent bottling partners, who handle manufacturing, packaging, and distribution alongside wholesalers and retailers. This asset-light structure, common in the Consumer Staples sector, allows Coca-Cola to focus on brand marketing and concentrate production while bottlers manage capital-intensive operations. Its shares trade on the NYSE under the ticker KO, and the company has been publicly listed since 1919.
- Fairlife and BodyArmor premium portfolio lifts operating margins
- Strong dollar pressures international revenue translation
- North America sparkling volumes soften on health-conscious shift
| Net Income: 14.3b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 13.94 > 1.0 |
| NWC/Revenue: 15.31% < 20% (prev 9.91%; Δ 5.40% < -1%) |
| CFO/TA 0.15 > 3% & CFO 16.3b > Net Income 14.3b |
| Net Debt (28.5b) to EBITDA (19.8b): 1.44 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago -0.02% < -2% |
| Gross Margin: 61.89% > 18% (prev 61.43%; Δ 0.46% > 0.5%) |
| Asset Turnover: 47.23% > 50% (prev 45.11%; Δ 2.13% > 0%) |
| Interest Coverage Ratio: 12.00 > 6 (EBIT TTM 18.8b / Interest Expense TTM 1.57b) |
| A: 0.07 (Total Current Assets 32.9b - Total Current Liabilities 25.2b) / Total Assets 108b |
| B: 0.78 (Retained Earnings 84.2b / Total Assets 108b) |
| C: 0.18 (EBIT TTM 18.8b / Avg Total Assets 106b) |
| D: 0.52 (Book Value of Equity 36.1b / Total Liabilities 69.6b) |
| Altman-Z'' = 4.74 = AA |
| DSRI: 0.84 (Receivables 3.73b/4.17b, Revenue 50.1b/47.1b) |
| GMI: 0.99 (GM 61.43% / 61.89%) |
| AQI: 0.94 (AQ_t 0.61 / AQ_t-1 0.64) |
| SGI: 1.07 (Revenue 50.1b / 47.1b) |
| TATA: -0.02 (NI 14.3b - CFO 16.3b) / TA 108b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of October 20, 2026, the stock is trading at USD 93.42 with a total of 16,925,328 shares traded. Over the past week, the price has changed by +4.04%, over one month by +7.23%, over three months by +14.44% and over the past year by +40.13%.
Current recommended Stop Loss: 90.20 (which is 3.4% or 2.2 ATR below the current price).
The Coca-Cola has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KO.
- StrongBuy: 12
- Buy: 7
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 94.5 | 1.2% |
P/E Trailing = 27.6276
P/E Forward = 25.3165
P/S = 7.8963
P/B = 10.5463
P/EG = 4.025
Revenue TTM = 50.1b USD
EBIT TTM = 18.8b USD
EBITDA TTM = 19.8b USD
Long Term Debt = 37.0b USD (from longTermDebt, last quarter)
Short Term Debt = 6.54b USD (from shortTermDebt, last quarter)
Debt = 44.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 28.5b USD (calculated: Debt 44.9b - CCE 16.4b)
Enterprise Value = 424b USD (396b + Debt 44.9b - CCE 16.4b)
Interest Coverage Ratio = 12.00 (Ebit TTM 18.8b / Interest Expense TTM 1.57b)
EV/FCF = 29.68x (Enterprise Value 424b / FCF TTM 14.3b)
FCF Yield = 3.37% (FCF TTM 14.3b / Enterprise Value 424b)
FCF Margin = 28.52% (FCF TTM 14.3b / Revenue TTM 50.1b)
Net Margin = 28.56% (Net Income TTM 14.3b / Revenue TTM 50.1b)
Gross Margin = 61.89% ((Revenue TTM 50.1b - Cost of Revenue TTM 19.1b) / Revenue TTM)
Gross Margin QoQ = 62.89% (prev 62.96%)
Tobins Q-Ratio = 3.93 (Enterprise Value 424b / Total Assets 108b)
Interest Expense / Debt = 3.49% (Interest Expense 1.57b / Debt 44.9b)
Taxrate = 16.41% (2.83b / 17.2b)
NOPAT = 15.7b (EBIT 18.8b * (1 - 16.41%))
Current Ratio = 1.30 (Total Current Assets 32.9b / Total Current Liabilities 25.2b)
Debt / Equity = 1.24 (Debt 44.9b / totalStockholderEquity, last quarter 36.1b)
Debt / EBITDA = 1.44 (Net Debt 28.5b / EBITDA 19.8b)
Debt / FCF = 1.99 (Net Debt 28.5b / FCF TTM 14.3b)
Total Stockholder Equity = 33.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.49% (Net Income 14.3b / Total Assets 108b)
RoE = 42.99% (Net Income TTM 14.3b / Total Stockholder Equity 33.3b)
RoCE = 26.74% (EBIT 18.8b / Capital Employed (Equity 33.3b + L.T.Debt 37.0b))
RoIC = 18.11% (NOPAT 15.7b / Invested Capital 86.8b)
WACC = 4.20% (E(396b)/V(441b) * Re(4.34%) + D(44.9b)/V(441b) * Rd(3.49%) * (1-Tc(0.16)))
Discount Rate = 4.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.23 | Cagr: -0.09%
[DCF] Terminal Value 75.44% ; FCFF base≈14.3b ; Y1≈14.4b ; Y5≈15.2b
[DCF] Fair Price = 48.35 (EV 237b - Net Debt 28.5b = Equity 208b / Shares 4.30b; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 98.19 | EPS CAGR: 6.68% | SUE: 4.0 | # QB: 5
Revenue Correlation: 95.08 | Revenue CAGR: 3.26% | SUE: 0.54 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.88 | Chg30d=+0.24% | Revisions=+25% | Analysts=18
EPS current Year (2026-12-31): EPS=3.30 | Chg30d=+0.05% | Revisions=+25% | GrowthEPS=+10.1% | GrowthRev=+3.7%
EPS next Year (2027-12-31): EPS=3.52 | Chg30d=-0.12% | Revisions=+0% | GrowthEPS=+6.6% | GrowthRev=-0.1%
[Analyst] Revisions Ratio: +22% (up=4, down=2)